Get the Stockscreener App
6.622
1.05%
-0.058
Kamada Ltd stock is traded at $6.622, with a volume of 7,476.
It is down -1.05% in the last 24 hours and down -4.62% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$6.68
Open:
$6.76
24h Volume:
7,476
Relative Volume:
0.12
Market Cap:
$384.13M
Revenue:
$154.57M
Net Income/Loss:
$15.07M
P/E Ratio:
24.53
EPS:
0.27
Net Cash Flow:
$10.92M
1W Performance:
-5.44%
1M Performance:
-4.62%
6M Performance:
-3.22%
1Y Performance:
+12.99%
1-Day Range:
$6.595
$6.76
1-Week Range:
$6.595
$7.05
52-Week Range:
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
6.60 | 384.13M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
118.75 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.29 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.915 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.02 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
472.86 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Kamada's (TLV:KMDA) Performance Is Even Better Than Its Earnings Suggest - simplywall.st
How supply chain issues affect Kamada Ltd. stockFed Meeting & Capital Efficient Trading Techniques - newser.com
Why Kamada Ltd. stock is favored by pension funds2025 Market Overview & Weekly Market Pulse Updates - newser.com
Is Kamada Ltd. stock resilient to inflationJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Using Ichimoku Cloud for Kamada Ltd. technicalsEarnings Performance Report & Technical Pattern Alert System - newser.com
How Kamada Ltd. stock compares to growth peersGlobal Markets & High Conviction Trade Alerts - newser.com
Is Kamada Ltd. stock in correction or buying zone2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Why Kamada Ltd. stock is in analyst buy zoneWeekly Market Report & Weekly Top Gainers Alerts - newser.com
Risk adjusted return profile for Kamada Ltd. analyzedJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
How Kamada Ltd. stock performs in stagflationTrade Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Kamada Ltd. Reports Strong Growth Amid Challenges - MSN
Is Kamada Ltd. stock attractive after correction2025 Major Catalysts & Safe Capital Growth Trade Ideas - newser.com
Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year - NewMediaWire
Price action breakdown for Kamada Ltd.2025 Analyst Calls & Precise Buy Zone Tips - newser.com
What’s next for Kamada Ltd. stock priceEarnings Overview Summary & Safe Entry Point Identification - newser.com
Does Kamada Ltd. show high probability of reboundPortfolio Value Summary & Weekly Market Pulse Updates - newser.com
Kamada (NASDAQ:KMDA) Rating Lowered to Buy at Wall Street Zen - Defense World
Is Kamada Ltd a good long term investmentSupport Zone Identification & Small Investment Trading Growth - earlytimes.in
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
2.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):